BioSpace News Archive

Novan, Inc. (“the Company” or “Novan”) (Nasdaq:NOVN) today announced that Paula Brown Stafford, currently President and Chief Operating Officer (“COO”) of Novan, will succeed G. Kelly Martin as its Chief Executive Officer (“CEO”), effective February 2, 2020, and she will remain a member of the Novan Board of Directors.

Deerfield Commits up to $130 million to Accelerate Drug Discovery at Duke Through a Newly Launched Company

Study Published in Psychopharmacology and Presented at the 12th Clinical Trials on Alzheimer’s Disease (CTAD) Shows Favorable Safety and Tolerability Profile of Regular Low Dose LSD

Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) is pleased to announce that the American Association of Clinical Endocrinologists (AACE) and American College of Endocrinology (ACE) have recently published the new ‘Guidelines for Management of Growth Hormone Deficiency in Adults and Patients transitioning from Pediatric to Adult Care’.

Proceeds provide sufficient funds to extend operations and ongoing trials late into the fourth quarter of 2020 Company does not intend to raise additional capital for ninety days following the closing of the offering NEWTOWN, Pa., Dec. 18, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova” or the “Company”), a Phase 3-stage biopharmaceutical company discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes (

BLISS-LN achieves primary endpoint and all major secondary endpoints

Bigda will be responsible for overseeing the scaling and optimization of business operations for Seven Bridges.

Company will use the funding to expand its real-world data cloud and clinical registries for real-world evidence and personalized medicine

Company Extends Long-Time Presence for Cutting-Edge Immunotherapy Manufacturing Facility through 2029

Called BLISS-LN, this trial is the largest one ever conducted among patients with lupus nephritis and paves the way for a new treatment for lupus nephritis.